Triple
T13942290
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pfizer–BioNTech |
E335285
|
entity |
| Predicate | hasRegulatoryApprovalFor |
P24602
|
FINISHED |
| Object | Pfizer–BioNTech COVID‑19 vaccine |
E812198
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pfizer–BioNTech COVID‑19 vaccine | Statement: [Pfizer–BioNTech, hasRegulatoryApprovalFor, Pfizer–BioNTech COVID‑19 vaccine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Pfizer–BioNTech COVID‑19 vaccine Context triple: [Pfizer–BioNTech, hasRegulatoryApprovalFor, Pfizer–BioNTech COVID‑19 vaccine]
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
C.
Pfizer–BioNTech
Pfizer–BioNTech is a pharmaceutical partnership best known for developing one of the first widely authorized mRNA vaccines against COVID-19.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
BNT162b2
chosen
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasRegulatoryApprovalFor Context triple: [Pfizer–BioNTech, hasRegulatoryApprovalFor, Pfizer–BioNTech COVID‑19 vaccine]
-
A.
hasRegulatoryApproval
chosen
Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
-
B.
FDAApprovalType
Indicates the specific regulatory pathway or category under which a product has been approved by the U.S. Food and Drug Administration.
-
C.
regulatoryApprovalYear
Indicates the calendar year in which an official regulatory body granted approval for the referenced item, action, or entity.
-
D.
regulationStatus
Indicates the regulatory condition or compliance state that applies to an entity under relevant rules or laws.
-
E.
hasRegulatedBy
Indicates that one entity is subject to control, governance, or rules imposed by another entity.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c6081b88190b53e317c3370c8fe |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e0f6f3c8190a64058b732b0ac52 |
completed | April 14, 2026, 12:07 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fba1ca49a881909e77b5a2ae13265f |
completed | May 6, 2026, 8:17 p.m. |
| PD | Predicate disambiguation | batch_69de05a3ccf88190b45c742db483fa08 |
completed | April 14, 2026, 9:15 a.m. |
Created at: April 9, 2026, 10:17 p.m.